Preclinical studies demonstrated that intrarenal RAS in individuals with diabetes was inappropriately activated, leading to local Ang II overproduction in proximal tubular cells, mesangial cells, and podocyte, although the systemic RAS was generally suppressed [12–14, 35]. This evidence concerns the gene AGT and diabetes mellitus.